97 related articles for article (PubMed ID: 12351692)
21. The Thyroid Na+/I- Symporter: Molecular Characterization and Genomic Regulation.
Alotaibi H; Tuzlakoğlu-Öztürk M; Tazebay UH
Mol Imaging Radionucl Ther; 2017 Feb; 26(Suppl 1):92-101. PubMed ID: 28117294
[TBL] [Abstract][Full Text] [Related]
22. An Enantiomer of an Oral Small-Molecule TSH Receptor Agonist Exhibits Improved Pharmacologic Properties.
Neumann S; Padia U; Cullen MJ; Eliseeva E; Nir EA; Place RF; Morgan SJ; Gershengorn MC
Front Endocrinol (Lausanne); 2016; 7():105. PubMed ID: 27512388
[TBL] [Abstract][Full Text] [Related]
23. Expression of Pax8 is decreased and bortezomib does not increase the iodine uptake in thyroid carcinoma cells.
Wang HJ; Yao JM; Zhang ZW; Zhao JY; Shang HX; Liao L; Dong JJ
Thorac Cancer; 2015 Nov; 6(6):792-6. PubMed ID: 26557920
[TBL] [Abstract][Full Text] [Related]
24. Modulation of sodium iodide symporter in thyroid cancer.
Lakshmanan A; Scarberry D; Shen DH; Jhiang SM
Horm Cancer; 2014 Dec; 5(6):363-73. PubMed ID: 25234361
[TBL] [Abstract][Full Text] [Related]
25. Sodium iodide symporter and the radioiodine treatment of thyroid carcinoma.
Chung JK; Youn HW; Kang JH; Lee HY; Kang KW
Nucl Med Mol Imaging; 2010 Apr; 44(1):4-14. PubMed ID: 24899932
[TBL] [Abstract][Full Text] [Related]
26. Physiological sodium concentrations enhance the iodide affinity of the Na+/I- symporter.
Nicola JP; Carrasco N; Amzel LM
Nat Commun; 2014 Jun; 5():3948. PubMed ID: 24888603
[TBL] [Abstract][Full Text] [Related]
27. Histone post-translational modifications induced by histone deacetylase inhibition in transcriptional control units of NIS gene.
Baldan F; Lavarone E; Di Loreto C; Filetti S; Russo D; Damante G; Puppin C
Mol Biol Rep; 2014 Aug; 41(8):5257-65. PubMed ID: 24844212
[TBL] [Abstract][Full Text] [Related]
28. Molecular cloning and functional characterization of two forms of Pax8 in the rainbow trout, Oncorhynchus mykiss.
Katagiri N; Uemae Y; Sakamoto J; Hidaka Y; Susa T; Kato Y; Kimura S; Suzuki M
Gen Comp Endocrinol; 2014 Mar; 198():22-31. PubMed ID: 24380675
[TBL] [Abstract][Full Text] [Related]
29. The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells.
Guerrieri F; Piconese S; Lacoste C; Schinzari V; Testoni B; Valogne Y; Gerbal-Chaloin S; Samuel D; Bréchot C; Faivre J; Levrero M
Cell Death Dis; 2013 Sep; 4(9):e807. PubMed ID: 24052075
[TBL] [Abstract][Full Text] [Related]
30. Hypothyroxinemia induced by mild iodine deficiency deregulats thyroid proteins during gestation and lactation in dams.
Wei W; Wang Y; Dong J; Wang Y; Min H; Song B; Shan Z; Teng W; Xi Q; Chen J
Int J Environ Res Public Health; 2013 Aug; 10(8):3233-45. PubMed ID: 23917811
[TBL] [Abstract][Full Text] [Related]
31. Sterol regulatory element-binding proteins are regulators of the NIS gene in thyroid cells.
Ringseis R; Rauer C; Rothe S; Gessner DK; Schütz LM; Luci S; Wen G; Eder K
Mol Endocrinol; 2013 May; 27(5):781-800. PubMed ID: 23542164
[TBL] [Abstract][Full Text] [Related]
32. The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.
Kogai T; Brent GA
Pharmacol Ther; 2012 Sep; 135(3):355-70. PubMed ID: 22750642
[TBL] [Abstract][Full Text] [Related]
33. Congenital Hypothyroidism Caused by a PAX8 Gene Mutation Manifested as Sodium/Iodide Symporter Gene Defect.
Jo W; Ishizu K; Fujieda K; Tajima T
J Thyroid Res; 2010; 2010():619013. PubMed ID: 21048839
[TBL] [Abstract][Full Text] [Related]
34. NF-kappaB p65 subunit mediates lipopolysaccharide-induced Na(+)/I(-) symporter gene expression by involving functional interaction with the paired domain transcription factor Pax8.
Nicola JP; Nazar M; Mascanfroni ID; Pellizas CG; Masini-Repiso AM
Mol Endocrinol; 2010 Sep; 24(9):1846-62. PubMed ID: 20667985
[TBL] [Abstract][Full Text] [Related]
35. The biology of the sodium iodide symporter and its potential for targeted gene delivery.
Hingorani M; Spitzweg C; Vassaux G; Newbold K; Melcher A; Pandha H; Vile R; Harrington K
Curr Cancer Drug Targets; 2010 Mar; 10(2):242-67. PubMed ID: 20201784
[TBL] [Abstract][Full Text] [Related]
36. Intronic elements in the Na+/I- symporter gene (NIS) interact with retinoic acid receptors and mediate initiation of transcription.
Alotaibi H; Yaman E; Salvatore D; Di Dato V; Telkoparan P; Di Lauro R; Tazebay UH
Nucleic Acids Res; 2010 Jun; 38(10):3172-85. PubMed ID: 20123735
[TBL] [Abstract][Full Text] [Related]
37. Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy.
Baril P; Martin-Duque P; Vassaux G
Br J Pharmacol; 2010 Feb; 159(4):761-71. PubMed ID: 19814733
[TBL] [Abstract][Full Text] [Related]
38. Single nucleotide variants of the TGACTCA motif modulate energetics and orientation of binding of the Jun-Fos heterodimeric transcription factor.
Seldeen KL; McDonald CB; Deegan BJ; Farooq A
Biochemistry; 2009 Mar; 48(9):1975-83. PubMed ID: 19215067
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways.
Kogai T; Ohashi E; Jacobs MS; Sajid-Crockett S; Fisher ML; Kanamoto Y; Brent GA
J Clin Endocrinol Metab; 2008 May; 93(5):1884-92. PubMed ID: 18319322
[TBL] [Abstract][Full Text] [Related]
40. Identification of cyclic adenosine 3',5'-monophosphate response element modulator as an activator of the human sodium/iodide symporter upstream enhancer.
Fenton MS; Marion KM; Hershman JM
Endocrinology; 2008 May; 149(5):2592-606. PubMed ID: 18202121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]